U.S. Hospitality Stock News

United Bancshares (UBOH) opened 2026 with Q4 2025 revenue of US$12.6 million and basic EPS of US$1.04, with trailing twelve month revenue at US$47.0 million and EPS at US$4.04 as the latest benchmark for earnings power. Over the past year, revenue has moved from US$41.8 million to US$47.0 million and basic EPS from US$3.06 to US$4.04, while the net profit margin on a trailing basis sits at 25.5% compared with 21.9% a year earlier, indicating a period where profitability expanded faster than...

Hormel Foods stock snapshot after recent performance Hormel Foods (HRL) trades around $21.19 with recent returns mixed, including an approximate 1.4% gain over the past day and a 1.5% move over the past week, alongside weaker performance over the past month and past 3 months. See our latest analysis for Hormel Foods. While the 1-day and 7-day share price returns are positive, the 30-day and 90-day share price returns are weaker, and the 1-year total shareholder return of around a 27% decline...

In April 2026, Infleqtion announced it had delivered an upgraded quantum hardware “physics package” for NASA’s Cold Atom Laboratory on the International Space Station via the NG-24 cargo mission, enabling more advanced dual-species ultracold atom experiments in microgravity. This upgrade, alongside Infleqtion’s broader role in space-based quantum sensing missions, underscores its emerging position in quantum infrastructure for aerospace, defense and critical infrastructure...

Investors may be considering whether Vertex Pharmaceuticals at around US$441 per share is offering fair value or if that price reflects a potential premium for growth prospects. The stock is up 1.1% over the last week, while the 1-year return is a 9.8% decline after a longer-term gain of 102.5% over 5 years. Recent headlines have focused on Vertex's pipeline progress and regulatory milestones, which can influence how investors think about future cash flows and risk. These updates help frame...

GigaCloud Technology (GCT) has returned to investor radar after announcing a marketplace initiative with Otto Group in Europe, along with renewed media attention following a high-profile interview with its chief executive. See our latest analysis for GigaCloud Technology. The recent Otto Group partnership and high profile CEO interview have arrived during a strong run, with a 30 day share price return of 28.5% and a 1 year total shareholder return above 300%, suggesting momentum and...

Union Pacific has proposed acquiring Norfolk Southern (NYSE:NSC) to form a transcontinental railroad spanning key U.S. freight corridors. The companies are discussing how a combined network could connect major coastal gateways with inland hubs across a single system. Management has emphasized careful integration planning to avoid operational issues seen in earlier large rail mergers. Norfolk Southern sits at the center of U.S. freight flows, with a core role in moving industrial goods,...

Diebold Nixdorf (NYSE:DBD) has been added to the S&P 600, S&P 1000, and S&P Composite 1500 indices. The index changes elevate the company’s visibility with institutional and index-tracking investors. The additions follow a period of strong share price performance and come with NYSE:DBD recently closing at $88.77. For investors watching NYSE:DBD, the index inclusions come after a sharp share price move, with the stock up 4.7% over the past week and 24.2% over the past month. The gain stands...

Wondering whether BrightSpring Health Services at US$47.27 is still offering value after a strong run? This article breaks down what that price could mean for you. The stock has posted returns of 4.3% over the last 7 days, 14.7% over 30 days, 23.1% year to date and 184.8% over the past year, which has put valuation questions firmly on the table. Recent coverage has focused on BrightSpring's position within the healthcare sector and investor interest around its public listing and business...

If you are wondering whether Guardant Health at around US$90.36 is still fairly priced or starting to look stretched, the key question is what that tag says about the underlying business. The stock has seen sharp swings, with a 15.0% move over the last 7 days, 6.1% over 30 days, a 100.9% return over 1 year and a 268.7% return over 3 years, while the 5 year return sits at a 42.9% decline and the year to date return at an 11.2% decline. Recent headlines around Guardant Health have focused on...

Earlier this month, Oxford BioTherapeutics announced a multi-year collaboration with Bristol Myers Squibb to discover and develop novel T‑cell engager therapies for solid tumours, using OBT’s OGAP‑Verify platform to identify tumour‑selective targets while BMS leads later-stage development and commercialisation. The deal deepens Bristol Myers Squibb’s oncology partnerships by giving it access to next-generation T‑cell engager candidates sourced and designed externally, potentially enriching...

Why Citi’s downgrade has put Flutter Entertainment (NYSE:FLUT) under closer scrutiny Citi’s downgrade of Flutter Entertainment (NYSE:FLUT) to sell, tied to concerns about US growth, profit targets, and possible delays to buybacks, has pushed investors to reassess the stock’s risk profile. See our latest analysis for Flutter Entertainment. At a share price of $110.08, Flutter’s 7 day share price return of 7.52% and 1 day gain of 0.94% sit against a 90 day share price return decline of 41.59%...

If you are wondering whether GE HealthCare Technologies is attractively priced or starting to look stretched, the current setup offers plenty for valuation focused investors to unpack. The stock last closed at US$74.66, with returns of 2.0% over 7 days, 7.2% over 30 days, a 9.9% decline year to date, and a 20.0% gain over 1 year, which gives a mixed picture of recent performance. Recent coverage has centered on GE HealthCare Technologies as a standalone medical technology player following...

Event context and recent share performance Luckin Coffee (OTCPK:LKNC.Y) has drawn investor attention after recent trading, with the stock last closing at $33.79 and showing a 3.5% one day move, alongside mixed returns over the month and past 3 months. See our latest analysis for Luckin Coffee. While the latest 3.5% one-day share price return has caught attention, the year-to-date share price return of a 4.6% decline contrasts with a 10.6% one-year total shareholder return and a very large...

Recently, a critical article highlighted that Selective Insurance Group’s earnings per share and book value growth have trailed peers, raising questions about management’s capital allocation and return on equity compared with other insurers. This negative analyst commentary has drawn attention to the gap between Selective’s current performance metrics and those of its industry rivals, putting management’s execution under closer investor scrutiny. Now we’ll examine how concerns over lagging...

EPAM Systems, Inc. previously proposed amending its Fourth Amended and Restated Certificate of Incorporation to allow shareholders to call special meetings, alongside urging investors in its April 6, 2026 definitive proxy filing to vote against a separate shareholder proposal seeking a 10% ownership threshold for calling such meetings. This contrast between management’s preferred approach and an activist-backed, lower threshold highlights an evolving power balance over how quickly investors...

Wondering whether Onto Innovation at around US$290.76 is offering good value or stretched pricing? This article breaks down what the current market is implying about the stock. The share price context includes a 13.1% return over the last 7 days, 45.3% over 30 days, 75.3% year to date, 152.9% over 1 year, 251.5% over 3 years and 315.5% over 5 years. These moves sit against a backdrop where investors are paying closer attention to semiconductor suppliers tied to advanced manufacturing and...

For readers wondering whether Woodward's recent share price puts it at a bargain or a stretch, this article walks through the numbers so you can judge how the current price lines up with underlying value. The stock last closed at US$394.83, with returns of 1.6% over 7 days, 11.7% over 30 days, 27.0% year to date, 134.4% over 1 year, 327.0% over 3 years and 228.0% over 5 years. These moves have kept Woodward on many investors' radar, with recent coverage focusing on what might be driving such...

Earnings, buybacks and credit quality in focus FB Financial (FBK) just reported first quarter 2026 results, with higher net interest income and net income than a year ago, alongside an update on share repurchases and credit costs. See our latest analysis for FB Financial. The latest results, share repurchases and relatively contained credit costs come against a backdrop of a 6.05% 1 month share price return and a 34.99% 1 year total shareholder return. This suggests momentum has been uneven...

Moderna recently presented positive Phase 1/2 data for its investigational cancer antigen therapy mRNA-4359 in combination with pembrolizumab in advanced melanoma, and the U.S. FDA granted the regimen Fast Track designation for a specific PD-L1 positive melanoma population. The strong early response and disease control rates, together with regulatory acceleration, highlight how Moderna is extending its mRNA platform beyond infectious disease vaccines into oncology. We’ll now examine how the...

Executive reshuffle puts technology and brand expansion in focus E.l.f. Beauty (ELF) has shaken up its leadership team, promoting longtime chief marketing officer Kory Marchisotto to president of E.l.f. Brands, naming Oshiya Savur as chief marketing officer, and creating a chief technology and AI officer role for Ekta Chopra. The company is explicitly positioning technology and artificial intelligence as central to its growth plans, a development that could influence how you think about the...

If you are wondering whether Amgen’s share price still offers value after a strong run, this breakdown will help you weigh what you are really paying for. At a last close of US$355.30, the stock has returned 1.2% over 7 days, 2.2% over 30 days, 8.4% year to date, 32.2% over 1 year, 60.1% over 3 years, and 61.7% over 5 years. These figures raise fair questions about what is already reflected in the price. Recent attention around Amgen has focused on its role as a large US biotech, with...

Generac Holdings (GNRC) recently announced a collaboration with CPower Energy to deploy distributed generation across the PJM market, focusing on battery storage, generators and microgrids for commercial and industrial customers. See our latest analysis for Generac Holdings. The latest partnership news comes as Generac’s share price, now at $212.10, has seen a 6.42% 1 month share price return and a 31.86% 3 month share price return, with 1 year total shareholder return of 89.85% pointing to...

Astronics (NasdaqGS:ATRO) has introduced its new EmPower Qi2 Wireless Charging Module for aircraft cabins, galleys, and crew rest areas. The module supports the latest Qi enabled and MagSafe compatible devices and is designed for rapid maintenance and compliance with aviation standards. Astronics focuses on aerospace and defense electronics, with cabin power and connectivity as a core part of its business. The EmPower Qi2 Wireless Charging Module fits directly into that franchise and aims...

Aktis Oncology (NasdaqGS: AKTS) has appointed Dr. Glenn Gormley as an independent director to its Board. Dr. Gormley will also serve as co-chair of a newly formed Science and Technology Committee. The company announced upcoming departures of two current Board members as part of this transition. Aktis Oncology, trading on NasdaqGS under the ticker AKTS, recently closed at $20.25. The stock is up 20.0% over the past week and 14.4% over the past 30 days, while the year-to-date return stands at...